Listed

IGC Pharma, Inc.

IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$265.0k, Q2 FY2027
Operating income−$2.8m, Q2 FY2027
Net income−$2.9m, Q2 FY2027
IGC Pharma, Inc., income statement, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20262026-03-31Q2 FY20272026-06-30
Revenue$k291Revenue, Q2 FY2024, three months to 2023-09-30$291.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure204Revenue, Q3 FY2024, three months to 2023-12-31$204.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure295Revenue, Q4 FY2024, three months to 2024-03-31$295.0k. XBRL concept us-gaap:Revenues. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure272Revenue, Q1 FY2025, three months to 2024-06-30$272.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure412Revenue, Q2 FY2025, three months to 2024-09-30$412.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure257Revenue, Q3 FY2025, three months to 2024-12-31$257.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure330Revenue, Q4 FY2025, three months to 2025-03-31$330.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure328Revenue, Q1 FY2026, three months to 2025-06-30$328.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure191Revenue, Q2 FY2026, three months to 2025-09-30$191.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure350Revenue, Q3 FY2026, three months to 2025-12-31$350.0k. XBRL concept us-gaap:Revenues. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure317Revenue, Q1 FY2026, three months to 2026-03-31$317.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure265Revenue, Q2 FY2027, three months to 2026-06-30$265.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Cost of revenue$k117Cost of revenue, Q2 FY2024, three months to 2023-09-30$117.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure71.0Cost of revenue, Q3 FY2024, three months to 2023-12-31$71.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure124Cost of revenue, Q4 FY2024, three months to 2024-03-31$124.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure109Cost of revenue, Q1 FY2025, three months to 2024-06-30$109.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure214Cost of revenue, Q2 FY2025, three months to 2024-09-30$214.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure153Cost of revenue, Q3 FY2025, three months to 2024-12-31$153.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure176Cost of revenue, Q4 FY2025, three months to 2025-03-31$176.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure174Cost of revenue, Q1 FY2026, three months to 2025-06-30$174.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure92.0Cost of revenue, Q2 FY2026, three months to 2025-09-30$92.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure306Cost of revenue, Q3 FY2026, three months to 2025-12-31$306.0k. XBRL concept us-gaap:CostOfRevenue. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure262Cost of revenue, Q1 FY2026, three months to 2026-03-31$262.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure217Cost of revenue, Q2 FY2027, three months to 2026-06-30$217.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Gross profit$k174Gross profit, Q2 FY2024, three months to 2023-09-30$174.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure133Gross profit, Q3 FY2024, three months to 2023-12-31$133.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure171Gross profit, Q4 FY2024, three months to 2024-03-31$171.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure163Gross profit, Q1 FY2025, three months to 2024-06-30$163.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure198Gross profit, Q2 FY2025, three months to 2024-09-30$198.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure104Gross profit, Q3 FY2025, three months to 2024-12-31$104.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure154Gross profit, Q4 FY2025, three months to 2025-03-31$154.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure154Gross profit, Q1 FY2026, three months to 2025-06-30$154.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure99.0Gross profit, Q2 FY2026, three months to 2025-09-30$99.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure44.0Gross profit, Q3 FY2026, three months to 2025-12-31$44.0k. XBRL concept us-gaap:GrossProfit. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure55.0Gross profit, Q1 FY2026, three months to 2026-03-31$55.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure48.0Gross profit, Q2 FY2027, three months to 2026-06-30$48.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Research and development$k1,268Research and development, Q2 FY2024, three months to 2023-09-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure903Research and development, Q3 FY2024, three months to 2023-12-31$903.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure855Research and development, Q4 FY2024, three months to 2024-03-31$855.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure889Research and development, Q1 FY2025, three months to 2024-06-30$889.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure917Research and development, Q2 FY2025, three months to 2024-09-30$917.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure852Research and development, Q3 FY2025, three months to 2024-12-31$852.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure997Research and development, Q4 FY2025, three months to 2025-03-31$997.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure851Research and development, Q1 FY2026, three months to 2025-06-30$851.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure1,588Research and development, Q2 FY2026, three months to 2025-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure1,482Research and development, Q3 FY2026, three months to 2025-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure1,272Research and development, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure1,390Research and development, Q2 FY2027, three months to 2026-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Selling, general and administrative$k1,397Selling, general and administrative, Q2 FY2024, three months to 2023-09-30$1.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure2,228Selling, general and administrative, Q3 FY2024, three months to 2023-12-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure1,486Selling, general and administrative, Q4 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure1,670Selling, general and administrative, Q1 FY2025, three months to 2024-06-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure1,041Selling, general and administrative, Q2 FY2025, three months to 2024-09-30$1.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure1,130Selling, general and administrative, Q3 FY2025, three months to 2024-12-31$1.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure570Selling, general and administrative, Q4 FY2025, three months to 2025-03-31$570.0k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure1,208Selling, general and administrative, Q1 FY2026, three months to 2025-06-30$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure1,410Selling, general and administrative, Q2 FY2026, three months to 2025-09-30$1.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure1,503Selling, general and administrative, Q3 FY2026, three months to 2025-12-31$1.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure1,241Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure1,442Selling, general and administrative, Q2 FY2027, three months to 2026-06-30$1.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Operating income$k(2,491)Operating income, Q2 FY2024, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure(2,998)Operating income, Q3 FY2024, three months to 2023-12-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure(2,170)Operating income, Q4 FY2024, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure(2,396)Operating income, Q1 FY2025, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure(1,760)Operating income, Q2 FY2025, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure(1,878)Operating income, Q3 FY2025, three months to 2024-12-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure(1,413)Operating income, Q4 FY2025, three months to 2025-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(1,905)Operating income, Q1 FY2026, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure(2,899)Operating income, Q2 FY2026, three months to 2025-09-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure(2,941)Operating income, Q3 FY2026, three months to 2025-12-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure(2,458)Operating income, Q1 FY2026, three months to 2026-03-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(2,784)Operating income, Q2 FY2027, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k0.0Income tax, Q2 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure0.0Income tax, Q3 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure0.0Income tax, Q2 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure0.0Income tax, Q3 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure0.0Income tax, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure0.0Income tax, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure0.0Income tax, Q2 FY2027, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Net income$k(2,451)Net income, Q2 FY2024, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure(5,589)Net income, Q3 FY2024, three months to 2023-12-31−$5.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure(2,885)Net income, Q4 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure(2,378)Net income, Q1 FY2025, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure(1,717)Net income, Q2 FY2025, three months to 2024-09-30−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure(1,829)Net income, Q3 FY2025, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure(1,198)Net income, Q4 FY2025, three months to 2025-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(1,599)Net income, Q1 FY2026, three months to 2025-06-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure(1,821)Net income, Q2 FY2026, three months to 2025-09-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure(726)Net income, Q3 FY2026, three months to 2025-12-31−$726.0k. XBRL concept us-gaap:NetIncomeLoss. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure(2,402)Net income, Q1 FY2026, three months to 2026-03-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(2,936)Net income, Q2 FY2027, three months to 2026-06-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Diluted EPS$ per share(0.05)Diluted EPS, Q2 FY2024, three months to 2023-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure(0.09)Diluted EPS, Q3 FY2024, three months to 2023-12-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2025, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure(0.02)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure(0.02)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure(0.02)Diluted EPS, Q4 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(0.02)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure(0.02)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(0.03)Diluted EPS, Q2 FY2027, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Basic EPS$ per share(0.05)Basic EPS, Q2 FY2024, three months to 2023-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure(0.09)Basic EPS, Q3 FY2024, three months to 2023-12-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figurenot reported(0.03)Basic EPS, Q1 FY2025, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure(0.02)Basic EPS, Q2 FY2025, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure(0.02)Basic EPS, Q3 FY2025, three months to 2024-12-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure(0.02)Basic EPS, Q4 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(0.02)Basic EPS, Q1 FY2026, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure(0.02)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(0.03)Basic EPS, Q2 FY2027, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure

Balance sheet

Cash and equivalents$331.0k, Q2 FY2027
Long-term debt$131.0k, FY2026
Shareholders' equity$6.1m, Q2 FY2027
IGC Pharma, Inc., balance sheet, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30FY20262025-12-31Q1 FY20262026-03-31Q2 FY20272026-06-30
Cash and equivalents$m3.0Cash and equivalents, Q2 FY2024, at 2023-09-30$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure1.4Cash and equivalents, Q3 FY2024, at 2023-12-31$1.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure1.2Cash and equivalents, FY2024, at 2024-03-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure1.8Cash and equivalents, Q1 FY2025, at 2024-06-30$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure1.5Cash and equivalents, Q2 FY2025, at 2024-09-30$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure0.5Cash and equivalents, Q3 FY2025, at 2024-12-31$470.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure0.4Cash and equivalents, FY2025, at 2025-03-31$405.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure0.5Cash and equivalents, Q1 FY2026, at 2025-06-30$454.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure1.1Cash and equivalents, Q2 FY2026, at 2025-09-30$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure0.9Cash and equivalents, FY2026, at 2025-12-31$900.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure0.2Cash and equivalents, Q1 FY2026, at 2026-03-31$207.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure0.3Cash and equivalents, Q2 FY2027, at 2026-06-30$331.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Current assets$m6.1Current assets, Q2 FY2024, at 2023-09-30$6.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure3.6Current assets, Q3 FY2024, at 2023-12-31$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure3.7Current assets, FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure4.4Current assets, Q1 FY2025, at 2024-06-30$4.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure4.3Current assets, Q2 FY2025, at 2024-09-30$4.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure3.1Current assets, Q3 FY2025, at 2024-12-31$3.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure2.9Current assets, FY2025, at 2025-03-31$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure2.2Current assets, Q1 FY2026, at 2025-06-30$2.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure2.0Current assets, Q2 FY2026, at 2025-09-30$2.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure1.8Current assets, FY2026, at 2025-12-31$1.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure1.1Current assets, Q1 FY2026, at 2026-03-31$1.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure1.3Current assets, Q2 FY2027, at 2026-06-30$1.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Total assets$m16.5Total assets, Q2 FY2024, at 2023-09-30$16.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure11.3Total assets, Q3 FY2024, at 2023-12-31$11.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure9.9Total assets, FY2024, at 2024-03-31$9.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure10.6Total assets, Q1 FY2025, at 2024-06-30$10.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure10.4Total assets, Q2 FY2025, at 2024-09-30$10.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure9.1Total assets, Q3 FY2025, at 2024-12-31$9.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure8.7Total assets, FY2025, at 2025-03-31$8.7m. XBRL concept us-gaap:Assets. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure7.9Total assets, Q1 FY2026, at 2025-06-30$7.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure9.7Total assets, Q2 FY2026, at 2025-09-30$9.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure9.7Total assets, FY2026, at 2025-12-31$9.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure9.2Total assets, Q1 FY2026, at 2026-03-31$9.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure9.5Total assets, Q2 FY2027, at 2026-06-30$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Current liabilities$m2.1Current liabilities, Q2 FY2024, at 2023-09-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure1.9Current liabilities, Q3 FY2024, at 2023-12-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure2.3Current liabilities, FY2024, at 2024-03-31$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure2.5Current liabilities, Q1 FY2025, at 2024-06-30$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure2.8Current liabilities, Q2 FY2025, at 2024-09-30$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure2.7Current liabilities, Q3 FY2025, at 2024-12-31$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure2.3Current liabilities, FY2025, at 2025-03-31$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure1.7Current liabilities, Q1 FY2026, at 2025-06-30$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure1.5Current liabilities, Q2 FY2026, at 2025-09-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure2.2Current liabilities, FY2026, at 2025-12-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure2.9Current liabilities, Q1 FY2026, at 2026-03-31$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure3.2Current liabilities, Q2 FY2027, at 2026-06-30$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Total liabilities$m2.4Total liabilities, Q2 FY2024, at 2023-09-30$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure2.2Total liabilities, Q3 FY2024, at 2023-12-31$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure2.6Total liabilities, FY2024, at 2024-03-31$2.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure2.7Total liabilities, Q1 FY2025, at 2024-06-30$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure3.0Total liabilities, Q2 FY2025, at 2024-09-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure2.8Total liabilities, Q3 FY2025, at 2024-12-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure2.4Total liabilities, FY2025, at 2025-03-31$2.4m. XBRL concept us-gaap:Liabilities. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure1.9Total liabilities, Q1 FY2026, at 2025-06-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure1.7Total liabilities, Q2 FY2026, at 2025-09-30$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure2.3Total liabilities, FY2026, at 2025-12-31$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure3.1Total liabilities, Q1 FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure3.4Total liabilities, Q2 FY2027, at 2026-06-30$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure
Long-term debt$m0.1Long-term debt, Q2 FY2024, at 2023-09-30$139.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure0.1Long-term debt, Q3 FY2024, at 2023-12-31$138.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure0.1Long-term debt, FY2024, at 2024-03-31$137.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure0.1Long-term debt, Q1 FY2025, at 2024-06-30$136.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure0.1Long-term debt, Q2 FY2025, at 2024-09-30$135.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure0.1Long-term debt, Q3 FY2025, at 2024-12-31$134.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure0.1Long-term debt, FY2025, at 2025-03-31$134.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure0.1Long-term debt, Q1 FY2026, at 2025-06-30$133.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure0.1Long-term debt, Q2 FY2026, at 2025-09-30$132.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure0.1Long-term debt, FY2026, at 2025-12-31$131.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figurenot reportednot reported
Short-term borrowings$m0.0Short-term borrowings, Q2 FY2024, at 2023-09-30$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2023-11-09, accession 0001185185-23-001163.Report this figure0.0Short-term borrowings, Q3 FY2024, at 2023-12-31$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-02-14, accession 0001185185-24-000160.Report this figure0.0Short-term borrowings, FY2024, at 2024-03-31$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-06-27, accession 0001185185-25-000706.Report this figure0.0Short-term borrowings, Q1 FY2025, at 2024-06-30$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-08-07, accession 0001185185-24-000766.Report this figure0.0Short-term borrowings, Q2 FY2025, at 2024-09-30$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure0.0Short-term borrowings, Q3 FY2025, at 2024-12-31$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure0.0Short-term borrowings, FY2025, at 2025-03-31$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure0.0Short-term borrowings, Q1 FY2026, at 2025-06-30$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure0.0Short-term borrowings, Q2 FY2026, at 2025-09-30$4.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure0.0Short-term borrowings, FY2026, at 2025-12-31$3.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figurenot reportednot reported
Shareholders' equity$m14.1Shareholders' equity, Q2 FY2024, at 2023-09-30$14.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure9.1Shareholders' equity, Q3 FY2024, at 2023-12-31$9.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure7.3Shareholders' equity, FY2024, at 2024-03-31$7.3m. XBRL concept us-gaap:StockholdersEquity. 10-KT filed 2026-03-18, accession 0001185185-26-000941.Report this figure7.9Shareholders' equity, Q1 FY2025, at 2024-06-30$7.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure7.4Shareholders' equity, Q2 FY2025, at 2024-09-30$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure6.3Shareholders' equity, Q3 FY2025, at 2024-12-31$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure6.3Shareholders' equity, FY2025, at 2025-03-31$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure6.1Shareholders' equity, Q1 FY2026, at 2025-06-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure8.1Shareholders' equity, Q2 FY2026, at 2025-09-30$8.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure7.4Shareholders' equity, FY2026, at 2025-12-31$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure6.1Shareholders' equity, Q1 FY2026, at 2026-03-31$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure6.1Shareholders' equity, Q2 FY2027, at 2026-06-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure

Cash flow

Operating cash flow−$1.4m, Q2 FY2027
Capital expenditure$5.0k, Q2 FY2027
IGC Pharma, Inc., cash flow, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20262026-03-31Q2 FY20272026-06-30
Operating cash flow$k(1,618)Operating cash flow, Q2 FY2024, three months to 2023-09-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001185185-24-001096. Derived: 6-month figure less the 3-month figure.Report this figure(1,587)Operating cash flow, Q3 FY2024, three months to 2023-12-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0001185185-25-000137. Derived: 9-month figure less the 6-month figure.Report this figure(526)Operating cash flow, Q4 FY2024, three months to 2024-03-31−$526.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure(1,752)Operating cash flow, Q1 FY2025, three months to 2024-06-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure(996)Operating cash flow, Q2 FY2025, three months to 2024-09-30−$996.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001185185-25-001752. Derived: 6-month figure less the 3-month figure.Report this figure(1,317)Operating cash flow, Q3 FY2025, three months to 2024-12-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure(730)Operating cash flow, Q4 FY2025, three months to 2025-03-31−$730.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(1,407)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure(2,090)Operating cash flow, Q2 FY2026, three months to 2025-09-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001185185-25-001752. Derived: 6-month figure less the 3-month figure.Report this figure(1,223)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure(1,223)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure(1,350)Operating cash flow, Q2 FY2027, three months to 2026-06-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001185185-26-003544. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k35.0Capital expenditure, Q2 FY2024, three months to 2023-09-30$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001185185-24-001096. Derived: 6-month figure less the 3-month figure.Report this figure68.0Capital expenditure, Q3 FY2024, three months to 2023-12-31$68.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-14, accession 0001185185-25-000137. Derived: 9-month figure less the 6-month figure.Report this figure15.0Capital expenditure, Q4 FY2024, three months to 2024-03-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-06-27, accession 0001185185-25-000706. Derived: 12-month figure less the 9-month figure.Report this figure38.0Capital expenditure, Q1 FY2025, three months to 2024-06-30$38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure29.0Capital expenditure, Q2 FY2025, three months to 2024-09-30$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001185185-25-001752. Derived: 6-month figure less the 3-month figure.Report this figure27.0Capital expenditure, Q3 FY2025, three months to 2024-12-31$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure18.0Capital expenditure, Q4 FY2025, three months to 2025-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure8.0Capital expenditure, Q1 FY2026, three months to 2025-06-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure29.0Capital expenditure, Q2 FY2026, three months to 2025-09-30$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001185185-25-001752. Derived: 6-month figure less the 3-month figure.Report this figure12.0Capital expenditure, Q3 FY2026, three months to 2025-12-31$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-KT filed 2026-03-18, accession 0001185185-26-000941. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure5.0Capital expenditure, Q2 FY2027, three months to 2026-06-30$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001185185-26-003544. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)100.33m, Q2 FY2027
IGC Pharma, Inc., shares, quarterly
Line itemUnitQ2 FY20182017-09-30Q3 FY20182017-12-31Q2 FY20242023-09-30Q3 FY20242023-12-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q1 FY20262026-03-31Q2 FY20272026-06-30
Diluted shares (weighted)m shares29.1Diluted shares (weighted), Q2 FY2018, three months to 2017-09-3029,051,771 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2017-11-17, accession 0001185185-17-002428.Report this figure28.2Diluted shares (weighted), Q3 FY2018, three months to 2017-12-3128,169,292 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2018-02-20, accession 0001185185-18-000276.Report this figure54.3Diluted shares (weighted), Q2 FY2024, three months to 2023-09-3054,301,087 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001185185-24-001096.Report this figure63.7Diluted shares (weighted), Q3 FY2024, three months to 2023-12-3163,725,084 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure72.8Diluted shares (weighted), Q1 FY2025, three months to 2024-06-3072,813,538 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001185185-25-000997.Report this figure76.0Diluted shares (weighted), Q2 FY2025, three months to 2024-09-3076,007,129 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure77.6Diluted shares (weighted), Q3 FY2025, three months to 2024-12-3177,633,004 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001185185-25-000137.Report this figure79.7Diluted shares (weighted), Q4 FY2025, three months to 2025-03-3179,658,429 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure83.0Diluted shares (weighted), Q1 FY2026, three months to 2025-06-3083,027,117 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure90.5Diluted shares (weighted), Q2 FY2026, three months to 2025-09-3090,457,910 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001185185-25-001752.Report this figure98.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3198,161,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001185185-26-001885.Report this figure100Diluted shares (weighted), Q2 FY2027, three months to 2026-06-30100,331,320 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure

Shares outstanding: 103.38mShares outstanding, period not labelled, at 2026-08-05103,384,008 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001185185-26-003544.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.